Using the Kaplan-Meier survival analysis in the GEO dataset GSE9891 29, GSE26193 30, we found that ovarian cancer patients with high CASC15 expression had worse overall survival (OS) than those with low CASC15 expression (Figure 1A and Figure S1A). This evidence concerns the gene CASC15 and ovarian cancer.